Azovudine tablet is a kind of medicine that has attracted more attention recently. It can treat new coronal disease and alleviate various discomfort caused by new coronal disease to a certain extent. The use of Azovudine tablets is also very particular. Not all people can eat it. For example, patients with diabetes and hypertension should be cautious in taking it.
Can I take Neocrown Azovudine Tablets for Diabetes
Use with caution.
Azovudine tablets are prescription drugs with strict indications, contraindications and precautions, and they need to be used under the guidance of doctors.
Because in the clinical study of this drug, patients with serious chronic diseases, metabolic diseases (such as diabetes), neurological and mental diseases were excluded, so there was no relevant experimental safety certification results for this type of population, so these patients should be cautious when taking Azovudine tablets to avoid aggravating their own conditions.
Is Azovudine Edible for Hypertension
It is recommended to take it under the guidance of a doctor.
Hypertension belongs to cardiovascular disease. According to the instructions of Azovudine, cardiovascular disease is not a contraindication of the drug, so patients with hypertension can take Azovudine under the guidance of doctors.
In addition, hypertension is one of the high risk factors. After taking Azovudine, it can effectively prevent the new crown from developing into severe disease. Generally speaking, the earlier you take Azovudine, the more obvious the effect will be. However, if you have allergies to Azovudine or any other component in the preparation, it is forbidden to take it.
Who is suitable for Azovudine Tablets
Azovudine is a nucleoside analog that inhibits viral RNA dependent RNA polymerase (RdRp), phosphorylates into an active 5 '- triphosphate metabolite in cells, and can inhibit the activity of recombinant HIV reverse transcriptase, leading to the suspension of viral DNA chain synthesis; It can also specifically act on the new coronavirus RdRp, thereby inhibiting virus replication.
At present, Azovudine tablets are suitable for adult patients infected with COVID-19, but research on the elderly aged 60 years and above is limited, and its safety and whether dose adjustment is needed are lack of data support. Experts suggest that it should be used in patients with positive nucleic acid in the early stage after infection of the new crown.
